DFDA

LAMA Monotherapy (e.g., Tiotropium)

Treatment for Copd

Typical Dosage: Tiotropium 18 mcg or 2.5 mcg once daily

Effectiveness
80%
Safety Score
55%
Clinical Trials
100
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
Tiotropium 18 mcg or 2.5 mcg once daily
Time to Effect
30 minutes (bronchodilation), days-weeks (symptoms)
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
10(Treat 10 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$4,500
Monitoring:$800
Side Effect Mgmt:$80
Total Annual:$5,380
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$40,000/QALY
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$8,967
Comparison vs SABA (e.g., Albuterol)
Cost Difference
+$3,750/year
More expensive
QALY Difference
+0.07 QALYs
Better outcomes
Dominance
No dominance
LAMA Monotherapy (e.g., Tiotropium) Outcomes

for Copd

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+60%
Common Side Effects
Dry mouth
+15%
Pharyngitis
+10%
Upper respiratory tract infection
+8%
Sinusitis
+5%
Constipation
+3%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov